Emory University School of Medicine
Dr. Lechowicz received her B.A. from Hofstra University, Hemptead, New York with the distinction of cum laude. She then earned her M.D. from the State University of New York in Syracuse, New York where she ranked third clinically in her third and fourth year. Dr. Lechowicz completed her internship, residency, and chief residency at Columbia Presybyterian Medical Center in New York, New York. She went on to complete a fellowship in oncology at the Sidney Kimmel Cancer Center at Johns Hopkins in Baltimore, Maryland. Prior to joining Emory in 2005, Dr. Lechowicz spent two years at the Georgia Cancer Center for Excellence at Grady Hospital where she developed the first attending only clinic for HIV and non-AIDS defined cancer patients.
Dr. Lechowicz’s research focuses on novel therapies for Hodgkin’s Disease HIV-related lymphomas, including cutaneous and peripheral T-cell lymphomas. Her interest in HIV and malignancies began with her training at Johns Hopkins. Dr. Lechowicz is the primary investigator for 14 trials at Emory University with regard to improvement of care in non-Hodgkin’s lymphomas, particularly related to transplantation and diffused B-cell lymphomas; cutaneous and peripheral lymphomas; T-cell lymphomas; and HIV and lymphoma care.
Dr. Lechowicz has ongoing research in the areas of cutaneous T-cell lymphoma, more specifically a collaboration with Dr. R. Halkar in nuclear medicine. This collaboration investigates the use of PET scanning for staging in cutaneous T-cell lymphoma patients. To note, this collaboration resulted in an abstract which was presented at the North American T-Cell Consortium in 2010 and is moving toward publication. Additionally, Dr. Lechowicz was editor for the American Society of Hematology Daily News in 2010, she has served on multiple committees including: the United States Cutaneous Lymphoma Consortium, American Society of Hematology, the ethics committee at Columbia Presbyterian Medical Center at Johns Hopkins, the ECOG Core Committee, and the Lymphoma Research Foundation’s Lymphoma Awareness Multicultural Population Advisory Committee.
View publications on PubMed